Isofol to host investor and scientific update on arfolitixorin study progress
Isofol will host an Investor & Scientific Update in Stockholm on Nov. 12, 2026. Session will cover recent progress on arfolitixorin, including data from an ongoing phase Ib/II colorectal cancer study. A follow-up investor meeting in Gothenburg on Nov. 13, 2026 will recap key messages from the Stockholm event. Disclaime